Medifast, Inc. (MED) Income Annual - Discounting Cash Flows
MED
Medifast, Inc.
MED (NYSE)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2003
12-31
2002
12-31
2001
12-31
2000
12-31
1999
12-31
1998
12-31
1997
12-31
1996
12-31
Report Filing 2026-02-17 2026-02-17 2025-02-18 2024-02-20 2023-02-21 2022-02-23 2021-02-26 2020-03-02 2019-03-01 2018-03-16 2017-03-16 2016-03-15 2015-03-16 2014-03-17 2013-03-15 2012-03-15 2011-04-01 2010-03-31 2009-03-16 2008-03-17 2007-03-16 2006-03-15 2005-05-31 2004-03-15 2003-03-25 2002-03-08 2001-03-29 2000-04-10 1999-04-15 1998-04-15 1997-04-08
Revenue 385.8 385.8 602.5 1,072 1,599 1,526 934.8 713.7 501 301.6 274.5 272.8 285.3 356.9 356.7 298.2 0.258 165.6 105.4 83.78 74.09 40.13 27.34 25.38 12.35 5.02 3.9 4.65 15.9 14.36 16.5
Cost of Revenue 110.6 110.6 157.8 296.2 458.2 398.5 237 176.8 121.1 73.75 68.87 71.46 76.08 89.04 88.67 73.69 0.065 40.29 25.33 21.46 18.24 10.16 6.75 6.83 3.69 2.21 1.72 2.31 10.1 9.67 9.22
Gross Profit 275.2 275.2 444.6 775.9 1,140 1,128 697.8 536.9 379.9 227.8 205.7 201.3 209.2 267.8 268 224.5 0.192 125.3 80.11 62.31 55.85 29.97 20.59 18.55 8.66 2.81 2.17 2.35 5.8 4.69 7.29
Operating Expenses 289.4 289.4 441.7 649.4 955.6 911.4 563.7 445.8 310.8 188.2 178.8 172.6 179 234.3 244.8 197.1 0.161 106 71.91 56.6 47.74 25.89 17.59 14.96 6.91 2.07 1.91 4.41 6.58 7.83 6.84
Research & Development 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Selling, General and Administrative 289.4 289.4 441.7 649.4 955.6 911.4 563.7 445.8 310.8 188.2 178.8 172.6 179 202.2 208.8 197.1 160.8 105.9 71.91 56.6 48.27 25.89 17.59 14.96 6.91 2.07 1.69 4.18 6.58 7.83 6.46
Other Operating Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 32.1 36 0 -160.7 0.068 0 0 -0.533 0 0 0 0 0 0.219 0.232 0 0 0.388
Operating Income -14.21 -14.21 2.88 126.4 184.8 216.2 134.2 91.04 69.06 39.63 26.86 28.68 30.25 33.59 23.26 27.38 0.032 19.37 8.2 5.71 8.11 4.07 3 3.6 1.75 0.745 0.266 -2.06 -0.771 -3.14 0.445
Net Non-Operating Interest 5.52 5.52 4.8 2.49 -0.701 0 0.246 1.29 1.31 0.558 0.283 0.661 0.716 0.509 0.304 0.319 0 0.01 -0.217 0 -0.194 -0.159 0 -0.15 0 0 -0.386 0 0 0 0
Interest Income 5.52 5.52 4.8 2.49 0 0 0.246 1.29 1.31 0.558 0.283 0.661 0.716 0.509 0.304 0.421 0 0.155 0.149 0 0.175 0.158 0 0 0 0 0 0 0 0 0
Interest Expense 0 0 0 0 0.701 0 0 0 0 0 0 0 0 0 0 0.102 0 0.145 0.366 0 0.369 0.317 0 0.15 0 0 0.386 0 0 0 0
Equity & Other Income/(Expense) 3.06 3.06 -3.9 -0.095 -0.046 -0.112 -0.14 0.029 0.179 0.136 -0.02 0.326 0.731 0.088 0.892 -0.021 -0 -0.083 -0.132 -0.172 -0.58 0.015 -0.098 0.11 -0.054 -0.179 0.033 0.339 -0.178 -0.217 -0.216
Income Before Tax -5.64 -5.64 3.79 128.8 184.1 216.1 134.3 92.36 70.55 40.33 27.12 29.67 31.69 34.19 24.46 27.68 0.032 19.29 7.85 5.54 7.34 3.93 2.91 3.56 1.7 0.566 -0.087 -1.73 -0.949 -3.35 0.229
Income Tax Expense 13.03 13.03 1.7 29.38 40.49 52.1 31.41 14.45 14.76 12.61 9.29 10.1 10.66 10.22 8.58 9.14 0.012 7.33 2.42 1.71 2.26 1.2 1.16 1.15 -0.925 -0.022 -0.787 1.13 0 0.342 -0.091
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 0 -0.491 7.85 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.603 0.339 0 0 0
Net Income -18.67 -18.67 2.09 99.42 143.6 164 102.9 77.92 55.79 27.72 17.84 20.06 13.18 23.97 15.88 18.54 0.02 11.96 5.43 3.84 5.08 2.73 1.75 2.41 2.62 0.588 1.3 -3.19 -0.949 -3.7 0.32
Depreciation and Amortization 14.24 10.5 12.71 13.11 10.98 6.81 4.32 4.62 4.43 4.21 5.41 7.12 8.05 7.9 8.38 8.34 5.86 5.27 4.57 3.47 2.4 1.74 1.21 0.648 0.321 0.211 0.219 0.232 0.431 0.875 0.662
EBITDA 0.03 -3.71 15.59 139.5 195.8 223.1 138.5 95.66 73.5 43.84 32.26 35.8 38.3 41.49 31.65 35.73 5.89 24.63 12.77 9.19 10.51 5.82 4.21 4.25 2.07 0.956 0.485 -1.83 -0.34 -2.26 1.11
Earnings Per Share (EPS) -1.7 -1.7 0.19 9.1 12.82 14.01 8.74 6.62 4.67 2.32 1.51 1.68 1.04 1.74 1.16 1.33 1.39 0.89 0.37 0.3 0.41 0.2 0.16 0.25 0.36 0.08 0.19 -0.58 -0.2 -0.86 0.07
Diluted Earnings Per Share -1.71 -1.7 0.19 9.1 12.73 13.89 8.68 6.43 4.62 2.29 1.49 1.66 1.03 1.73 1.16 1.31 1.35 0.81 0.34 0.28 0.38 0.19 0.14 0.22 0.3 0.07 0.17 -0.58 -0.2 -0.86 0.07
Weighted Average Shares Outstanding 10.99 10.98 10.93 10.88 11.2 11.71 11.77 11.77 11.95 11.92 11.84 11.96 12.67 13.77 13.72 13.97 14.08 13.52 13.13 12.96 12.7 12.26 10.83 9.31 6.72 6.52 5.63 5.48 4.8 4.3 4.31
Diluted Weighted Average Shares Outstanding 10.99 10.98 10.96 10.92 11.28 11.81 11.85 12.12 12.08 12.09 11.95 12.07 12.78 13.82 13.74 14.2 14.57 14.73 14.33 13.64 13.48 12.78 12.41 10.95 8.74 8.07 7.38 5.48 4.8 4.3 4.31
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program